U.S. flag

An official website of the United States government

NM_001372044.2(SHANK3):c.4600G>A (p.Gly1534Arg) AND Phelan-McDermid syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 10, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003127574.2

Allele description [Variation Report for NM_001372044.2(SHANK3):c.4600G>A (p.Gly1534Arg)]

NM_001372044.2(SHANK3):c.4600G>A (p.Gly1534Arg)

Gene:
SHANK3:SH3 and multiple ankyrin repeat domains 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.33
Genomic location:
Preferred name:
NM_001372044.2(SHANK3):c.4600G>A (p.Gly1534Arg)
Other names:
chr22:51160636G>A
HGVS:
  • NC_000022.11:g.50722208G>A
  • NG_070230.1:g.57992G>A
  • NM_001372044.2:c.4600G>AMANE SELECT
  • NP_001358973.1:p.Gly1534Arg
  • NC_000022.10:g.51160636G>A
Protein change:
G1534R
Links:
dbSNP: rs1440735830
NCBI 1000 Genomes Browser:
rs1440735830
Molecular consequence:
  • NM_001372044.2:c.4600G>A - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
probably no functional consequence
Observations:
2

Condition(s)

Name:
Phelan-McDermid syndrome
Synonyms:
TELOMERIC 22q13 MONOSOMY SYNDROME; 22q13.3 deletion syndrome; Chromosome 22q13.3 deletion syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011652; MedGen: C1853490; Orphanet: 48652; OMIM: 606232

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003803637Laboratory of Functional Genomics, Research Centre for Medical Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jan 10, 2023)
paternal, unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownno1not providednot providednot providednot providedclinical testing
not providedpaternalyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory of Functional Genomics, Research Centre for Medical Genetics, SCV003803637.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
11not providednot providedclinical testing PubMed (1)
21not providednot providedclinical testing PubMed (1)

Description

Proband is a three year-old boy with a psycho-speech delay. Heterozygous missense variant NM_001372044.2 (SHANK3):c.4600G>A was found by WGS. Segregation analysis by Sanger sequencing revealed the variant in proband and his healthy father. According to ACMG, the variant meets the criteria PM2, PP2, BS4 and is concidered as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1paternalyesnot providednot providednot provided1not providednot providednot provided
2unknownnonot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 20, 2024